Sanjiv Bhasin की TCS, HCL Tech, Divis Lab और Sun Pharma Share पर राय | Kamai Ka Adda

आज बाजार की शानदार तेज़ी के बाद हम जाएंगे Sanjiv Bhasin की top shares पर राय. साथ में जानें आज उनकी आज बजट पर क्या राय है और आगे उनकी क्या रणनीति है

#ShareMarketLive #CNBCAwaazLive #Budget2021 #Budget2021ShareMarket #Budget2021CNBCAwaaz
CNBC Awaaz is India’s number one business channel and an undisputed leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence.

Subscribe to the CNBC Awaaz YouTube channel here: https://tinyurl.com/y5rsvesk

Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz
Like us on our CNBC Awaaz Facebook page: https://www.facebook.com/cnbcawaaz

Видео Sanjiv Bhasin की TCS, HCL Tech, Divis Lab और Sun Pharma Share पर राय | Kamai Ka Adda канала CNBC Awaaz